Table 1.
Group 1 - HAART (n = 53) |
Group 2 - NAÏVE (n = 24) |
p value | |
---|---|---|---|
Age (years); median (range) | 42 (28–54) | 39 (25–49) | NS |
Duration of HIV-1 infection (years); median (range) | 14 (3–32) | 5 (1–27) | NS |
Time under HAART (years); median (range) | 8 (1–14) | – | |
CD4 count (cells/ml); median (range) | 470 (71–1670) | 445 (149–1086) | NS |
Undetectable viral load, n (%) | 53 (100%) | 24 (100%) | |
Educational level | |||
High school, n (%) | 24 (45.3) | 12 (50) | NS |
University, n (%) | 5 (9.4) | 3 (12.5) | NS |
Unknown, n (%) | 24 (45.3) | 9 (37.5) | NS |
Employed, n (%) | 48 (90.6) | 21 (87.5) | NS |
Route of HIV-1 transmission | |||
Injection drugs, n (%) | 2 (4%) | 1 (4%) | NS |
Sexual transmission, n (%) | 31 (58%) | 21 (88%) | NS |
Blood product transmission, n (%) | 20 (38%) | 2 (8%) | NS |
Note. The comparison between groups was performed using χ2 or exact tests for categorical variables and Mann–Whitney U test for continuous variables. Statistically significant difference as p < .05. HAART = highly-active antiretroviral therapy; NS = not significant.